4d Molecular Therapeutics In shares owned by Citigroup
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $975k | 90k | 10.79 |
| 2024-06-30 | $1.7M | 83k | 21.00 |
| 2024-03-31 | $4.9M | 153k | 31.90 |
| 2023-12-31 | $847k | 41k | 20.50 |
| 2023-09-30 | $696k | 55k | 12.73 |
| 2023-03-31 | $1.9M | 112k | 17.19 |
| 2022-12-31 | $573k | 26k | 22.21 |
| 2022-09-30 | $80k | 9.9k | 8.09 |
| 2021-12-31 | $1.8M | 83k | 21.94 |
| 2021-03-31 | $59k | 1.4k | 43.13 |